ストックスクリーナーアプリを入手
12.11
7.35%
-0.96
アフターアワーズ：
12.15
0.04
+0.33%
Replimune Group Inc (REPL) 最新ニュース
Why Is REPL Stock Soaring 127% After Hours Today? - Stocktwits
Replimune Group, Inc. (REPL) Options Chain - Yahoo! Finance Canada
Replimune Group, Inc. (REPL) Stock Price, News, Quote & History - Yahoo! Finance Canada
Replimune Group (REPL) Launches TUDRIQEV As Its Valuation Story Comes Into Focus - Yahoo Finance
(REPL) Movement as an Input in Quant Signal Sets - Stock Traders Daily
7R8.HM Interactive Stock Chart | Replimune Group Inc. R Stock - Yahoo! Finance Canada
Levi & Korsinsky Urges Replimune Group, Inc. (REPL) Shareholders to Act Before Lead Plaintiff Deadline October 5, 2026 - ACCESS Newswire
FDA Staff Raise Concerns On Replimune’s Skin Cancer Drug – REPL Stock Crashes 32% Today Ahead Of Advisory Meeting This Week - Stocktwits
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - WBOC TV
Replimune Group, Inc. (REPL) Options Chain - Yahoo! Finance Canada
Levi & Korsinsky Urges Replimune Group, Inc. (REPL) Shareholders to Act Before Lead Plaintiff Deadline October 5, 2026 - ACCESS Newswire
Securities Lawsuit Alert: Replimune Group, Inc. (REPL)Contact Levi & Korsinsky Before October 5, 2026 - ACCESS Newswire
Lost Money on Replimune Group, Inc. (REPL)? Join Class Action Before October 5, 2026Contact Levi & Korsinsky - ACCESS Newswire
REPLIMUNE CLASS ACTION DEADLINE MONDAY: Bragar Eagel & - GlobeNewswire
REPLIMUNE CLASS ACTION DEADLINE MONDAY: Bragar Eagel & - GlobeNewswire
REPLIMUNE CLASS ACTION DEADLINE MONDAY: Bragar Eagel & Squire, P.C. Urgently Reminds Replimune Group Inc. Investors to Contact the Firm Seeking Lead Plaintiff Role Before October 5th - GlobeNewswire Inc.
Insiders At Replimune Group Sold US$1.6m In Stock, Alluding To Potential Weakness - Moomoo
REPL UPCOMING DEADLINE: Levi & Korsinsky Alerts Replimune Group, Inc. Stockholders of Securities Class ActionContact the Firm - FinancialContent
Replimune Group, Inc. (7R8.MU) stock price, news, quote and history - Yahoo Finance Australia
Replimune launches melanoma therapy in US market - Investing.com
Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma - FinancialContent
Replimune Announces TUDRIQEV™ Now Available in the U.S. for Advanced Melanoma - Yahoo Finance
Replimune CEO and CFO sued for allegedly mislea... - Pluang
SueWallSt Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 5, 2026REPL - PR Newswire
SueWallSt Reminds Replimune Group, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of October 5, 2026REPL - TradingView
REPL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Replimune Group, Inc. Securities LawsuitContact Levi & Korsinsky - Morningstar
REPL Shareholder Alert: Investors With Losses May Seek to Lead the Class Action in Replimune Group, Inc. Securities LawsuitContact Levi & Korsinsky - PR Newswire
Operating margin % of Replimune Group, Inc. – HAN:7R8 - TradingView
Lost Money on Replimune Group, Inc. (REPL)? Contact Levi & Korsinsky Before October 5, 2026 to Join Class Action - ACCESS Newswire
REPLIMUNE CLASS ACTION DEADLINE MONDAY: Bragar Eagel & - GlobeNewswire
Portnoy Law Firm Announces Class Action on Behalf of Replimune Group, Inc. Investors - GlobeNewswire
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, - GlobeNewswire
REPL Investor Alert: Replimune Group, Inc. Securities Class Action NoticeContact Levi & Korsinsky - GlobeNewswire
ETFs Investing in Replimune Group, Inc. Stocks - TradingView
Investor Alert: Deadline Approaching to Join Replimune Group, Inc. (REPL) Class ActionContact Levi & Korsinsky - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Replimune Group, - GlobeNewswire
Replimune faces securities lawsuit over alleged misleading FDA trial data claims on RP1 drug resubmission. - Pluang
REPL Deadline Alert: SueWallSt Reminds Replimune Group, Inc. (REPL) Investors of Securities Class Action Deadline on October 5, 2026 - PR Newswire
REPL UPCOMING DEADLINE: Levi & Korsinsky Alerts Replimune Group, Inc. Stockholders of Securities Class ActionContact the Firm - PR Newswire
Securities Lawsuit Alert: Replimune Group, Inc. (REPL)Contact Levi & Korsinsky Before October 5, 2026 - ACCESS Newswire
Replimune stock gains as share authorization doubles - AD HOC NEWS
Portnoy Law Firm Announces Class Action on Behalf of Replimune Group, Inc. Investors - GlobeNewswire
REPL Stock Clocks Worst Day In Over 3 Months — New FDA Documents Leave Wall Street Awaiting Another Rejection For Cancer Drug - Stocktwits
REPL Investors Have Opportunity to Lead Replimune Group, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
Replimune Group, Inc. (REPL) Stock Analysis: A Potential 51.52% Upside In Biotech Innovations - DirectorsTalk Interviews
REPL Shareholder Alert: Replimune Group, Inc. Securities Class Action LawsuitInvestors With Losses May Contact SueWallSt - PR Newswire
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of October 5, 2026 in Replimune Group, Inc. LawsuitREPL - Morningstar
REPL INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Replimune Group, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
REPL Stock DropRobbins LLP Reminds Investors They May Be - GlobeNewswire
8.37%
0.06%
大文字化:
|
ボリューム (24 時間):